NCT01721707View on ClinicalTrials.gov

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Latanoprost+Brinzolamide combination

1 drop in each eye, 1x/day, at 9PM

DRUG

Latanoprost

1 drop in each eye, 1x/day, at 9PM

Trial Locations (1)

04023062

Department of Ophthalmology / Hospital São Paulo, São Paulo

Sponsors
All Listed Sponsors
lead

Adapt Produtos Oftalmológicos Ltda.

INDUSTRY

NCT01721707 - Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH | Biotech Hunter | Biotech Hunter